Purchase Order 75N91018P00318

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on June 7, 2018, with a ceiling value of $4,300.08 and ultimate completion date of June 14, 2019. The order is priced as firm fixed price with no set-aside. Place of performance is Marlborough, Massachusetts. The specific procurement details and commodity description are not provided in the source material.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $11,440 on March 8, 2018, with completion by March 27, 2019. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside applied. Specific scope of supply is not detailed in the award record.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on April 17, 2018, for $6,222.68 with an ultimate completion date of May 26, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. The specific goods or services procured are not described in the source documentation.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $97,997.20 on April 4, 2017, for maintenance services for a Delta Vision OMX instrument. The order is firm fixed price with no small business set-aside. Place of performance is Marlborough, Massachusetts. The ultimate completion date is April 3, 2022.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on June 27, 2018, with a ceiling value of $7,422.68. The order, issued under firm fixed pricing, calls for delivery to Bethesda, Maryland, with an ultimate completion date of July 8, 2019. No set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on August 8, 2019, with a ceiling value of $18,641.70 for firm fixed price procurement. The place of performance is Bethesda, Maryland 20814. No set-aside category was applied. The order ultimate completion date is August 7, 2020.</p>

The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC valued at $17,871.00 on February 1, 2018, with an ultimate completion date of January 31, 2019. The order carries fixed-price pricing with economic price adjustment and covers scientific equipment and consumables to be delivered to Bethesda, Maryland. Global Life Sciences Solutions is a wholly owned subsidiary of Danaher Corporation and competes full-and-open without small business set-asides.

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $14,350 on December 5, 2019, for a service agreement covering scientific equipment. Place of performance is Bethesda, Maryland. The order carries a firm fixed price and has an ultimate completion date of December 2, 2020. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $16,422.00 on June 27, 2018, for an OMX standalone workstation. Place of performance is Marlborough, Massachusetts. The order is firm fixed price with an ultimate completion date of July 24, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $1,617.96 on March 30, 2015, for field replaceable unit power supply assemblies, imaged hard drives, board assemblies, field labor (Tier 1), human resources support, and Zone 1 travel fees. No small business set-aside was used. Performance took place in Piscataway, New Jersey. The purchase order was priced firm fixed and completed on March 30, 2015.</p>